List view / Grid view
Researchers at the University of Alberta in Canada have discovered a unique process of brain cell death called pyroptosis that affects the cells that are most vulnerable in multiple sclerosis (MS).
EBV may trigger some cases of lupus, say NIH-supported researchers...
Researchers have developed a new imaging agent that could help guide and assess treatments for people with various neurological diseases...
Researchers have discovered that the EGFL7 protein inhibits the migration of immune cells into the brain...
Scientists have shown that skin cells re-programmed into brain stem cells, transplanted into the central nervous system, help reduce inflammation and may be able to help repair damage caused by MS...
Scientists have identified identified key regulators that are essential for controlling the inflammatory response in Crohn’s disease and multiple sclerosis.
CXCR7 receptor identified as a potential therapeutic target for controlling multiple sclerosis, Parkinson's and AIDS...
MRIs can reveal changes in the brain associated with MS before the clinical symptoms of the disease appear in children...
Scientists have uncovered two closely related cytokines molecules involved in cell communication that explain why some people develop progressive MS...
The ubiquitous human herpes virus 6 (HHV-6) may play a critical role in impeding the brain's ability to repair itself in diseases like multiple sclerosis.
Medically active substances are usually distributed via the blood – either directly or indirectly. In many diseases, however, it is vital to transport the active substance as efficiently as possible to the required target site. This is the case for diseases of the central nervous system, so the treatment of…
In this project, universities and companies across 11 European countries and the US will unite efforts to tailor the development and application of therapies to the individual MS patient.
9 November 2016 | By Dr Hervé Perron, co-founder and Chief Scientific Officer of GeNeuro
GeNeuro's co-founder and CSO Dr Hervé Perron discusses how a HERV protein could be a target for a novel approach in treating multiple sclerosis...
16 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Inhibition of the protein kinase CK2 results in a blockade of exactly those signal pathways required by TH17 cells in order to evolve...
4 August 2016 | By Niamh Marriott, Digital Content Producer
Chronos Therapeutics, a biotech company researching ageing diseases, brain and nervous system disorders, have announced the appointment of Dr Fraser Murray and Dr Timothy Schulz-Utermoehl, as Vice Presidents of Pre-Clinical Development...
